200 related articles for article (PubMed ID: 20438535)
1. Retrospective analysis of long-term lipid apheresis at a single center.
Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
[TBL] [Abstract][Full Text] [Related]
2. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
Sosland RP; Gollub SB; Wilson DB; Moriarty PM
Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
[TBL] [Abstract][Full Text] [Related]
4. The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience.
Sampietro T; Sbrana F; Bigazzi F; Ripoli A; Dal Pino B; Pasanisi EM; Petersen C; Coceani M; Luciani R; Pianelli M
Atheroscler Suppl; 2015 May; 18():268-72. PubMed ID: 25936336
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein apheresis: plasma exchange or dextran sulfate adsorption apheresis.
Yavasoglu I; Kadikoylu G; Bolaman Z
Ther Apher Dial; 2008 Feb; 12(1):100-1; author reply 102. PubMed ID: 18257822
[No Abstract] [Full Text] [Related]
7. Lipid reductions by low-density lipoprotein apheresis: a comparison of three systems.
Jovin IS; Taborski U; Stehr A; Müller-Berghaus G
Metabolism; 2000 Nov; 49(11):1431-3. PubMed ID: 11092506
[TBL] [Abstract][Full Text] [Related]
8. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
Klingel R; Mausfeld P; Fassbender C; Goehlen B
Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
[TBL] [Abstract][Full Text] [Related]
9. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
[TBL] [Abstract][Full Text] [Related]
10. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
Seidel D
Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
12. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
Bosch T; Lennertz A; Schenzle D; Dräger J;
J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
[TBL] [Abstract][Full Text] [Related]
13. Factors inducing cardiovascular events in patients treated by lipoprotein apheresis.
Taseva K; Fischer S; Passauer J; Weiss N; Bornstein SR; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):45-50. PubMed ID: 23357140
[TBL] [Abstract][Full Text] [Related]
14. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy.
Ertorer ME; Guvenc B; Haydardedeoglu B; Tekinturhan F
Ther Apher Dial; 2008 Oct; 12(5):396-400. PubMed ID: 18937724
[TBL] [Abstract][Full Text] [Related]
15. Italian multicenter study on low-density lipoprotein apheresis Working Group 2009 survey.
Stefanutti C; Morozzi C; Di Giacomo S;
Ther Apher Dial; 2013 Apr; 17(2):169-78. PubMed ID: 23551673
[TBL] [Abstract][Full Text] [Related]
16. One year experience with a low density lipoprotein apheresis system.
Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
[TBL] [Abstract][Full Text] [Related]
17. [LDL apheresis using a double filtration technique. Results after a 6-to-12 month follow-up in patients with refractory hyperlipemia and ischemic heart disease].
Rubio Sanz R; Anaya F; López-Sendón JL; López de Sa E; Muñoz H; García E; Delcán JL
Rev Esp Cardiol; 1996 Apr; 49(4):270-6. PubMed ID: 8650403
[TBL] [Abstract][Full Text] [Related]
18. [Clinical long-term results of H.E.L.P.-apheresis].
Schuff-Werner P
Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
[TBL] [Abstract][Full Text] [Related]
19. Adverse events of lipoprotein apheresis and immunoadsorption at the Apheresis Center at the University Hospital Dresden.
Dittrich-Riediger J; Schatz U; Hohenstein B; Julius U
Atheroscler Suppl; 2015 May; 18():45-52. PubMed ID: 25936304
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies.
Bambauer R; Schiel R; Latza R
Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
